Philip was Vice President, Research and Development for Angiotech Pharmaceuticals. Philip Toleikis joined Sernova in 2022.
Philip Toleikis is currently Chief Technology Officer at Sernova - View - Sernova org chart
Create your alert
to follow the career of Philip Toleikis.
Philip Toleikis has a Master of Science in Zoology Physiology from University of Michigan and a PhD in Pharmacology and Therapeutics from University of British Columbia.
They have also studied at University of Michigan :
Find more alumni from University of Michigan
They have also studied at University of British Columbia :
Find more alumni from University of British Columbia
Do you need to know more about Philip Toleikis? More results.
Report an error
Update the org chart details of Philip Toleikis.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.